Philip Kern
Clinical trials sponsored by Philip Kern, explained in plain language.
-
Could common drugs turn back the clock on diabetes?
Disease control Recruiting nowThis study is testing if two existing medications, mirabegron and tadalafil, can help reverse prediabetes in obese adults. Researchers will give 96 participants either one drug, both drugs, or a placebo for 14 weeks to see if their blood sugar control improves. The goal is to see…
Phase: PHASE4 • Sponsor: Philip Kern • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Bladder pill trial aims to turn fat into a Sugar-Burning furnace
Disease control Recruiting nowThis study is testing if a drug called mirabegron, currently used for overactive bladder, can help people with prediabetes. Researchers want to see if the drug can activate special 'beige' fat in the body to improve how it handles sugar and insulin. The trial will enroll 65 adult…
Phase: PHASE2 • Sponsor: Philip Kern • Aim: Disease control
Last updated Mar 27, 2026 12:37 UTC